EDCTP side event at UNGA79 Science Summit

26 September 2024

Investing in clinical research in Africa to develop local solutions against the global challenge of Antimicrobial Resistance (AMR)

26 September 2024 11:00-13:00 EDT | 17:00-19:00 CET (Virtual)

As part of the Science Summit during the 79th United Nations General Assembly (SSUNGA79), EDCTP will organise a side event that aims to illustrate the value of investing in clinical research and development of accessible and affordable antibiotics, diagnostics, and vaccines for addressing unmet medical needs in Africa through a global partnership such as EDCTP.

The objectives of the session will be to:

Promote awareness about EDCTP and its role and contribution towards attaining the SDGs.
Highlight the role of R&D in tackling AMR and showcase practical examples of how the EDCTP programmes have supported clinical research on AMR.
Discuss the priority elements for mitigating AMR and achieving the SDGs, including adopting a One Heath approach, ensuring equitable access to antimicrobials, recognising prevention as the cornerstone of response, and safeguarding adequate, sustainable and predictable financing for antibiotic, diagnostics, and vaccine development.

The side event will count with the participation of:

Yewande Alimi, Africa CDC.
David Barros, GlaxoSmithKline.
Julia Anna Bielicki, Paediatric Infectious Diseases and Infection Prevention and Control at the University of Basel Children’s Hospital.
Joseph Fokam, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB).
Samuel Kariuki, Drugs for Neglected Diseases initiative (DNDi).
Michael Makanga, Executive Director at Global Health EDCTP3.
Irene Norstedt, Directorate People: Health & Society, Directorate-General for Research and Innovation (DG RTD).
Francine Ntoumi, Congolese Foundation for Medical Research (FCRM).
Marcel Tanner, Swiss Academy of Sciences.
Marleen Temmerman, Aga Khan University.
Lara Pandya, Communications & Strategic Partnerships at Global Health EDCTP3 (convenor).

We are happy to announce that Michael Makanga, Executive Director of Global Health EDCTP3, will also be participating virtually in two other plenaries: